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Abstract: This thesis is about the medical adverse outcome prediction and is composed of
three parts, i.e. feature selection, time-to-event prediction and personalized modeling. For
feature selection, we proposed a three-stage feature selection method which is an ensemble of
filter, embedded and wrapper selection techniques. We combine them in a way to select a
both stable and predictive set of features as well as reduce the computation burden. Datasets
on two adverse outcome prediction problems, 30-day hip fracture readmission and diabetic
retinopathy prognosis are derived from electronic health records and exemplified to prove
the effectiveness of the proposed method. With the selected features, we investigated the
application of some classical survival analysis models, namely the accelerated failure time
models, Cox proportional hazard regression models and mixture cure models on adverse
outcome prediction. Unlike binary classifiers, survival analysis methods consider both the
status and time-to-event information and provide more flexibility when we are interested
in the occurrence of adverse outcome in different time windows. Lastly, we introduced the
use of personalized modeling(PM) to predict adverse outcome based on the most similar
patients of each query patient. Different from the commonly used global modeling approach,
PM builds prediction model on smaller but more similar patient cohort thus leading to a
more individual-based prediction and customized risk factor profile. Both static and metric
learning distance measures are used to identify similar patient cohort. We show that PM
together with feature selection achieves better prediction performance by using only similar
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Adverse medical outcome refers to the suboptimal outcome of patients, like mortality,
readmission and cancer diagnosis, and it has brought huge economic burden to the healthcare
system. Hospital readmission is one important example of adverse outcome, which is not
only costly but also life-threatening.[1–3] For example, hip fracture (HF) is one serious injury
that frequently occurs in the geriatric population and leads to 20-25% first-year mortality
rate[4, 5], even worse, readmission within 30 days after hip fractures can nearly double the
first-year mortality rate [4]. Hospitals with more frequent readmission are believed to be
providing poorer healthcare and will be penalized by the Centers for Medicare & Medicaid
Services (CMS).[6] The onset of disease is another often-discussed topic in adverse outcome
research. One example is the onset of diabetic retinopathy (DR), a complication of diabetes
which can cause damage to patients’ retina. Once it occurs the lost vision can’t be regained
and it has been a leading cause of blindness in American adults.[7] Fortunately, many of the
adverse outcome can be prevented through predictive analysis and targeted treatment based
on the predicted results, especially in such an era of advanced information technology and a
large amount of rich, quality longitudinal patient data that is conducive to making accurate
predictions.
Predictive modeling has been one of the most popular and important techniques
in the study of clinical adverse outcome. [8–12] Generally speaking, predictive modeling
involves four key steps, as shown in Figure 1.1, including data acquisition, feature selection,
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model development and evaluation.[13–19] Although there are other factors that can influence
the prediction performance of models, like the treatment of missing data, they are often
the limitations of all models and complicated tasks which varies by problem. The focus of
this investigation is on improving the prediction accuracy by optimizing the listed steps of
predictive modeling.
Figure 1.1. General Steps of Predictive Modeling
For the acquisition of data, with the passage of the Health Information Technology for
Economic and Clinical Health (HITECH) Act in 2009 and the Affordable Care Act (ACA) in
2010, many hospitals have transitioned to the electronic health records (EHRs) system and
the use of EHRs has grown dramatically. By 2014, 75.5% of hospitals were using EHRs.[20]
The extensive adoption of EHRs has ensured that we can obtain a huge amount of data
that contains various information about patients. EHRs record the patients’ medical history
over time, including demographics, medications, vital signs, laboratory data, physician’s
notes, etc. With such tremendous information and easier access, EHRs have become an
important data source for medical research. Cerner Health Facts Database (Kansas City,
MO) is such an EHRs database which we will conduct our analysis on. With this reliable
data source, we will be able to obtain sufficient cohort size which is a key to accurate prediction.
Despite the rich information in EHRs data, we should also note that its exploration
is challenging due to the variation in different data sources, data quality issues, inherent
case heterogeneity and high dimensional nature.[21–24] Among all these problems, in this
work, our focus will be on alleviating the high dimensional problem. Due to the high dimen-
sionality of the data, it usually causes a huge computational burden, and also introduces a
lot of redundant and irrelevant information which may affect the prediction performance.
Feature selection is a technique to address this problem, by choosing features that are truly
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associated with the response variable.[25] It can not only improve accuracy but also speed up
model fitting and enhance interpretability. In clinical research, it can even help to reduce
the costs by identifying the unnecessary lab tests[26], and provide targeted guidance on
post-discharge care planning. Besides fitting prediction models, the selected features can
also be used to derive risk scores to quantify the risk of patients’ developing adverse medical
condition.[20, 27–29] A common requirement for medical risk score is its simplicity and
good interpretability, which again emphasizes the importance of choosing the smallest set
of significant features. Feature selection has been extensively studied in recent years and
various algorithms have been derived.[30] Different methods, like machine learning models,
information theory, designed experiments and fuzzy modeling, have been proposed to identify
significant features.[26, 31–33] But there is a lack of general guideline for feature selection in
adverse outcome prediction and the stability of selection process seems to be overlooked. A
more detailed review on feature selection techniques will be present in Chapter II.
When predictive features are selected, the choice of an appropriate modeling framework
according to the data types is critical to the final prediction performance. After reviewing
the current models used in adverse outcome prediction [34–37], we identified two potential
directions to improve the model development step, that is, the application of survival analysis
and personalized modeling. Binary classifiers like logistic regression have often been used
in the adverse outcome prediction since the outcome is usually dichotomous, like “readmit-
ted” versus “non-readmitted”. But actually, the time-to-event information are oftentimes
available or can be converted from the data and the inclusion of this information may lead
to more accurate prediction.[37, 38] For example, when we are trying to identify the 30-day
readmission status of patients, we first need to calculate days from the index admission to
the re-hospitalization and then label the patients as “readmitted” or “non-readmitted” based
on whether the number of days exceed 30. If we analogize non-readmission as survival, the
days to readmission can be taken as survival days and survival analysis is needed. In this
work, we will explore the application of survival analysis on readmission prediction.
In adverse outcome prediction studies, we also notice that the most straightforward
and popular approach is to build a single classifier using all of the available training observa-
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tions and then predict the outcome of patients entering the system in the future, which has
been referred to as one-size-fits-all approach or global model.[39] Global model can capture
the patterns prevalent in the entire population but may miss the less popular information
that is important for specific patients. Thus, global models usually perform well for the
average patients but are sub-optimal for individual patients with unique characteristics[40].
Other researchers also point out that the global model is not robust to population shift.[41]
Population shift happens when the distributions of the training and test sets are different,
which is not unusual when we split the data into training and test sets chronologically. A
remedy to this is personalized predictive modeling which selects only the similar cases to
train the model on the individual basis. It has been a success in a variety of domains like the
personalized product recommendation in e-commerce, which is based on the belief that users
have similar tastes on some items may have the same taste on other items.[39] Its success
indicates the potential of improving adverse outcome prediction by building individual-based
prediction model with medical history of the most similar patients. Consequently, patients
will be able to receive care and service based on individual needs and conditions, which will
in turn improve disease prevention, management and drug prescription.
To summarize, this study intends to present a new automatic and stable ensemble
feature selection process which can reduce the number of features as well as maintain or even
improve prediction performance compared with the full model. It can also serve as a general
feature selection guideline for similar prediction researches that aim to achieve the smallest
stable feature set to build interpretable prediction model and derive simple risk scores. We
also explore improving prediction accuracy by including the time-to-event information with
survival analysis. To address the possible population shift problem, a personalized modeling
process is proposed, which can also generates individualized risk factor profiles. The outline
of this study is as follows. Chapter II briefly reviews the terminologies and concepts relevant
to the models or techniques that will be used through this paper. Chapter III introduces the
three-step ensemble feature selection method, the survival models and personalized modeling
steps. Two adverse outcomes, 30-day hip fracture readmission and diabetic retinopathy
prognosis, are exemplified to show the effectiveness of our proposed feature selection method
in Chapter IV. The applications of survival models on readmission prediction and personalized
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modeling on adverse outcome prediction are also discussed. Chapter V provides the discussion




The aim of this chapter is to investigate the recent trends in feature selection and
prediction modeling.
2.1 Predictive Modeling
Predictive modeling refers to the process of applying statistical techniques to historical
records to predict future outcomes. It is also defined as the process by which a model or a
mathematical tool is created to predict the probability of an outcome.[16, 42] It has been in
the intersection of statistical modeling, machine learning and database technology.[43] As
the need for future event prediction continues to growing in various fields, the application
of predictive modeling starts to be found everywhere, like the fraud detection systems of
banks[44] and the recommender systems of commercial service providers[45]. The applications
of predictive modeling has revolutionized many industries and at the same time, the develop-
ment of various industries also fueled the advances of modeling techniques.[46] The predictive
techniques have developed from regression models which emphasizes interpretability to more
sophisticated machine learning methods that focus more on accuracy.[16] In general, there
are two classes of predictive models, parametric and non-parametric models. The former type
makes specific assumptions on the parameters to characterize some underlying distributions
while the latter usually has no restriction on the distribution form.[47] The advantages of
parametric models include better interpretability, better ability to quantify the feature effect
as well as indicating the direction of the impact.
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Predictive analytics identifies the not-readily-apparent trends, patterns or relation-
ships among data and also produces insights to help practitioners understand how people
behave as customers, buyers, patients, and so on.[48–50] It has been widely used to assist
human decision-makers in various fields, including but not limited to, financial service[50, 51],
insurance[52, 53] and healthcare[54, 55]. For example, banks can decide whether to issue
an applicant the credit card based on fraud detection models.[56, 57] Predictive models are
also used in applications like crime detection[58] and email spam filter[49], estimating the
probability of a crime or email being spam. It is also one of the most important technologies
used in healthcare and clinical research, which can be reflected by the growing publication rate
of relevant papers.[59] This type of model in clinical practice is also referred to as prognostic
model, which predicts future events or behaviors and provides data-driven decision support
to healthcare providers[60–62]. For example, it helps doctors decide whether to provide
intensive or mild treatment to patients based on the predicted probability of readmission
risk.[63–65] Readmission is one type of medical adverse outcome, which refers to suboptimal
or unwanted event for patients following medical care and other examples include morbidity,
mortality, new disease or worsening symptoms, unscheduled physician visits and emergency
department visits.[66–68] A single-institution adverse outcome analysis[69] showed that about
25% of patients in their study had an adverse outcome and 50% of the occurrences could have
been prevented if predictive models are used appropriately and timely treatments are provided.
A systematic review paper[20] thoroughly reviewed 107 papers on medical outcome
prediction with electronic health records from 15 different countries. 78.5% of them used the
generalized linear models, including logistic regression and Cox regression, as the prediction
models. The regularized regression, like ridge regression and the least absolute shrinkage and
selection operator(LASSO) are also often incorporated for the purpose of variable selection.
They also point out that machine learning models are also used but more likely to include all
the variables. The c-statistic (i.e. the area under the receiver operating characteristic curve
(AUC)), a most commonly used measurement to evaluate the model performance, ranges
from 0 to 1 and the larger the value, the better the prediction performance.[70] They present
the distributions of c-statistics by the modelled outcome type and it shows that the model
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performance varies greatly among the same outcome type as well as among different outcome
types, and their c-statistic can be as low as less than 0.6 and as high as close to 1.
Although a large number of prediction models have been established, only a few are
used in clinical practice.[62] Possible reasons behind this include the insufficient size of cohort
which the model is built on, inappropriate processing of missing data, lack of interpretability,
unsuitable model framework and lack of transparent reporting of the above steps.[71, 72]
Missing data is universally encountered in clinical research since it’s difficult to collect all data
on all predictors for all patients. Handling missing values is a significant yet complicated task
and the necessity of treatment on missing data varies by models, thus there is no consensus on
how to deal with the missing problem.[73] The most popular and easiest approach in clinical
research is the complete case analysis, where all patient records with a missing value on any
of the considered features are excluded.[62, 74] In this study, we will take the complete case
analysis approach on the data and focus on solving the other key problems, including enlarging
cohort size, improving model interpretability and selecting suitable model framework, which
corresponds to the three key aspects of developing a prediction model[74, 75], i.e. data
acquisition, feature selection and model development.
2.2 Data Acquisition — Electronic Health Records (EHRs)
Advances in information technology contribute to the digitization of health and patient
data. Electronic health records (EHRs), the electronic version of patient health records,
was originally introduced to store and manage patient data effectively.[76] The authorities
have speed up the adoption of EHRs with legislation like Health Information Technology for
Economic and Clinical Health (HITECH) Act in 2009 and the Affordable Care Act (ACA) in
2010, which have pushed the industry to shift towards EHRs and there has been a dramatic
increase in their usage. In 2014, 75.5% of hospitals were using EHRs.[20] The wide application
of EHRs systems has guaranteed the access to rich, longitudinal admission records containing
rich information of patients.[77, 78] EHRs record the patients’ medical history over time,
which include demographics, medications, vital signs, laboratory data, physician notes, etc.
With such tremendous information and easy access, researchers have been actively exploring
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the secondary use of EHRs, such as patient risk stratification and disease detection.[20, 76, 79]
EHRs data is known to be rich in variety and large in volume. Variety means the var-
ious formats the patient information takes, including the structured value records, physicians’
prescription, symptoms description as well as the photographic or digital images.[80] Volume
refers to the fact that the databases are usually extremely large both in terms of the number
of features and the number of samples considered.[81, 82] The high dimensionality results
from improvements in data acquisition capacity, falling costs of data storage and computation,
development of database and data warehousing technology.[83] The rich information and
large volume of EHRs data present great potential since the access to more data instances
and more data features is critical for predictive modeling.[17]
2.3 Feature Selection
Although the big volume of the EHRs database brings rich patient information, it also
brings manifold challenges to predictive analytics. One challenge is that there are not only
predictive features but also many irrelevant or redundant features, which often increase the
size of search space and bring difficulty to the pattern learning in the data. There are two
groups of dimensionality reduction techniques: One is feature extraction where a new and
smaller set of features are usually constructed as the combination of existing features and has
often been used in computer vision problems.[82, 84, 85] Another type is feature selection
which entails choosing the smallest feature subset that can maximize the prediction accuracy.
Feature selection can not only reduce dimensionality but also maintain the interpretability
and it is believed to improve the robustness and usefulness of prediction algorithms by
selecting a small set of relevant features to construct the final model.[14, 86, 87]
Feature selection is a research topic of long history and has been more extensively
studied in the past decades because of the breakthrough in information technology and the
need to deal with high dimensional data.[13, 88–91] By identifying the most relevant subset
of features, feature selection techniques simplify the model and lead to better interpretability,
shortening computation time, reducing overfitting, etc.[92] In clinical practice, risk index or
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prognostic index which measures the risk of developing the outcome, is often derived after
fitting the final model with the selected most significant features.[61, 93] The index is defined
as a weighted sum of the features with their coefficient values as weight.[94–97] Given these
benefits, various feature selection techniques have been proposed, and can be classified in
different ways.[98] Based on the automaticity, they can be divided into the expertise-based
(knowledge-driven) and automatic (data-driven) approach[99]. The first type uses domain
knowledge to help assess the significance of a predictor and whether to include it in the final
model.[100, 101] On the contrary, data-driven approaches select features based on the analysis
and interpretation on data and have been extensively studied, especially in the machine
learning and artificial intelligence community.[89, 91] Although the expert knowledge is of
great importance to the interpretation of results, it may not be available all the time and
is subject to bias. In our study, we focus on the data-driven approaches. Depending on
the relationship between selection process and model building, the data-driven approaches
can be categorized into three major categories: filter, wrapper and embedded methods.[89, 93]
Filter methods select features independently from the classifier. In most cases, the
relevance of features to the dependent variable is evaluated and the highly relevant features
are selected as the input to the classification model. The common evaluation criteria include
distance metrics, data variance, fisher score, correlation, mutual information, Kolmogorov-
Smirnov test, T-test and Chi Square test.[102–104] Advantages of filter methods include their
scalability to high-dimensional datasets and the fast computation. Due to the simplicity
and fast-speed of univariate filter methods, they have been the most commonly used feature
selection technique. Chi-square test has been popular in evaluating the relevance of categorical
features and T-test for continuous ones.[29, 105–108]
Chi-square test was introduced by Pearson (1900), firstly used to test the good-
ness of fit and has been applied to test the dependence of two events. The test statistic
is derived on the independence rule of two events P (AB) = P (A)P (B). To test the
dependence between the binary outcome Y and a feature X, we have the contingency
table below, where nij(i, j = 0, 1) denotes the observed number of each event. Denote
the expected number of each event as eij(i, j = 0, 1). If X and Y are independent, we
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Event Y=1 Y=0 Total
X occurs n11 n10 n11 + n10
X not occur n01 n00 n01 + n00
Total n11 + n01 n10 + n00 n
Table 2.1. Contingency table of feature X and the outcome Y
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ni1+ni0
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An alternative to chi-square test is Fisher’s exact test when the expected values
in any cell of the contingency table are below 5.[108] For continuous variables, T-test is
most commonly used and sometimes Wilcoxon rank sum test or Mann-Whitney U test is
used instead.[107–110] Since filter methods consider each feature separately, they ignore
the feature dependencies. Additionally, these methods also ignore the interaction between
feature subspace and the classifier. As a result, filter methods often lack robustness against
interaction among features and also that between features and the classifier.[111]
On the contrary, wrapper methods embed the feature selection within the model
selection. Wrapper-type methods entail an exhaustive search of all possible subsets of features
to guarantee finding the best subset of features.[86] They train a new model for each subset
of features and test on a hold-out set to score feature subsets. The subset with the highest
score will be chosen thus they are tailored for specific models. They have the advantage of
considering both feature dependencies and the interaction between feature selection and model
building.[89, 93] Wrapper methods can be grouped into sub-categories by their searching
pattern, that is, greedy and randomized.[111] Examples of wrapper methods include the
forward and backward selection, which sequentially include or exclude features by means of
the loss function.[29, 112–114] The disadvantage of these methods is that they tend to overfit
the classifiers and are more computationally intensive than filter techniques.[93] Since the
wrapper methods are classifier-dependent, if we are interested in different classifiers, we need
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to perform feature selection for each of the classifiers separately, while we just need to do
feature selection once for filter techniques. Wrappers have also been criticized for requiring
massive amounts of computation, but efficient search strategies can be devised to address
this problem.[115]
For the third class of feature selection methods, embedded methods, the feature
selection process is integrated as part of the model construction, which means that they
are specific to a given model, like the wrapper approaches.[98] Embedded methods discover
the set of features from the model structure. Two popular examples are the decision tree
algorithm[116, 117] and regression with the least absolute shrinkage and selection operator
(LASSO)[118]. A decision tree can infer the variable importance by its node structure but a
single tree can be unstable.[119] As an alternative, random forest ensembles a forest of trees on
bagged samples and takes the average of variable importance to get an overall measure.[120]
LASSO has obtained success in many applications of dimension reduction but is known to be
unstable when features are correlated.[121] Actually, different feature selection techniques
can be cooperated together to reach a smaller set of features and maintain the performance.
Although most of the existing studies tend to use filter method or embedded method alone
for selection, one study combined Support Vector Machines (SVM) with various feature
selection methods, including a two-step one which used both the filter method F-score and
the embedded method random forest.[99] F-score is a simple measure for the discriminability
of a feature, defined as:
F (i) =
(x̄i





+ − ¯x+i )2 + 1n−−1
∑n−
k=1(x̄k,i
− − ¯x−i )2
(2.1)
This type of feature selection method is also called the hybrid method, which com-
bine different feature selection methods to integrate their advantages.[111] For example, the
filter-wrapper algorithms are proposed to reduce the computation burden of using wrapper
alone.[122] There are also empirical researches showing that we can benefit from feature
ranking aggregation and the fusion of a set of feature selection techniques.[123] It’s even
claimed that the future opportunities for feature selection research lies on new combinations
of existing techniques such as hybrid or ensemble methods and it’s possible to distribute
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the data vertically by features to reduce computational burden when applying wrapper
methods.[124, 125] This inspires us to propose the feature selection algorithm that integrates
the three types of methods in a computation-efficient way.
To evaluate and compare the performance of different techniques, there are two im-
portant aspects, i.e. accuracy and stability. Accuracy measures the predictive power of the
selected features while stability measures the degree of agreement of the feature subset selected
by the method when used on different training sets drawn from the same distribution.[93].
Accuracy has been commonly used to evaluate the performance while stability is often ignored.
Actually, the stability of feature selection is of great importance since it ensures the reliability
in real-world practice.[98, 115] To quantify the stability, we can measure the similarity of two
feature subsets and available methods include the Jaccard stability measure (JSM), Pearson’s
correlation coefficient (PCC) and Spearman’s rank correlation coefficient (SRCC).[93] It
has been shown that ensemble of different feature selection techniques and feature ranking
aggregation can strengthen the stability of selection.[14, 126–129] One recent study explored
the use of three embedded feature selection techniques together with six aggregation methods,
including three simple aggregation methods and their weighted versions.[41] They concluded
that the weighted mean rank performs the best in their scenario although the difference
between those aggregation methods were not significant. Thus, we will choose two represen-
tative aggregation methods in our research, i.e. ensemble by simple mean and ensemble by
weighted mean where the weight is the out-of-bag AUC.
2.4 Model Development
2.4.1 Time-to-event prediction
When defining the occurrence of an adverse outcome, it’s usually necessary to first
select an appropriate time frame. For example, different time frames are used to define
readmission and there are readmissions within 15 days, 30 days, 60 days and 90 days of
the initial admission to hospital.[130] Sometimes there is controversy on the choice of the
time frame and the associated risk factors may vary by different postdischarge days.[131]
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When researchers are interested in whether an adverse outcome will occur before a specific
time, the process is often treated as a classification problem predicting whether an adverse
outcome occurs before the specific time, without considering the time information, that is,
the time length until the occurrence of adverse outcome.[132] Instead of treating this as
a binary classification problem, if we take the time-to-event into account, the process can
be viewed as a survival analysis problem.[133] Similar to classification problems, survival
analysis problems are also about examining the associations between the adverse outcome
and the clinical predictors, but they care about not just whether it occurs but also the time
to the occurrence.[37, 134, 135] And we can predict the probability of an adverse outcome at
any time rather than at a certain time point, with survival analysis. Since the outcome is not
observed for all patients, censoring has to be considered and the standard regression methods
are not appropriate here. Various survival models are proposed to address these problems
and identify the associations[133], including the popular proportional hazards model[136]
and the accelerated failure time model[137]. Other researchers explored extensions of these
models by using specific parametric transformation[138] and time-varying covariates[37]. One
extension is the mixture cure model, which assumes that the studied population is a mixture
of susceptible individuals who may experience the event of interest, and cured individuals who
may never experience the event.[139] In this study, we aim to investigate the use time-to-event
prediction on adverse outcome problems with some classical survival analysis models.
2.4.2 Personalized modeling
In clinical studies, the most common practice of prediction modeling is to train a
one-size-fits-all classification model on all the labelled training records and then use the single
model to make prediction on any unlabeled new patient entering the system.[55, 100, 109]
This kind of population-based model usually works well on the average patients but may not
be able to capture the unique characteristics of specific patients.[40] Due to the specificity of
each patient to the treatment and medication and the variability of available data per patient,
the widely used one-size-fits-all models for risk evaluation are losing their power.[35, 48]
Another big challenge for population-based prediction modeling in medical research is the
study of commobidity, which is specific to patients and limits the generalization to common
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patients.[140] Its’s also discussed that the global model aims to learn a decision function
which can reach a low mistake rate on the whole data space thus may not work well on local
space.[141] One remedy to this is the personalized modeling, which is also known by different
names, like case-based training[142], instance-based training[143], transductive learning[48],
customized training[36] etc. Its core idea is using both the labeled and unlabeled data and
leveraging the similarity among individuals to build individualized prediction model with the
most similar records, instead of one general model. The example that we are most familiar
with is the neighbors-based model which doesn’t construct a general model but simply detect
the nearest neighbors of each point and make predictions from them.[144] It has been more
often discussed in personalized product and service recommendation systems[145, 146] and
personalized medicine[35], but not in adverse outcome prediction.
The relevant concept in healthcare delivery is the personalized medicine.[147] Re-
searches on personalized medicine shows that the patient population is heterogeneous and
each patient has unique characteristics thus requiring specific predictions, recommendations
and treatment.[35] But currently this term focuses on genetic data and has often been equated
to genomic medicine.[148] It’s shown that personalized health care recognizes the dynamic
relationship among genetic inheritance, environmental exposures and systems biology.[149]
Personalized medicine has often been discussed as a possible application in genomics informa-
tion practice. Besides the personalized modeling with genomic information alone, there is
also study that integrated both clinical factors and gene expression data to predict disease
outcome in a person-centered way.[150]
However, genomic information is not yet widely available in everyday clinical practice,
while EHRs are more accessible in the healthcare systems. It’s of great potential to per-
sonalize healthcare service by making use of EHRs’ tremendous clinical information, which
includes but not limited to demographics, diagnostic history, medications, laboratory test
results and vital signs.[151] A recent work on predicting diabetic kidney disease (DKD)
onset[41] concluded that the ignorance of population shift resulted in the performance drop
on their temporal validation data. A comparative research on global and personalized models
in bioinformatics problems pointed out that models on individualized patients were more
15
adaptable to both new data and features.[152] Another research pointed out that for many
machine learning techniques, the local structure of data space is more important than the
global structure, thus considering patients’ similarity and using most similar patients to
build predictive model will help to address these problems.[104] Motivated by this, we aim to
improve the adverse outcome prediction with person-based modeling techniques on EHRs data.
Patient similarity analytics have been used in various medical problems, like the target
patient retrieval, medical prognosis, risk stratification and clinical pathway analysis.[151]
More broadly, they can be applied to create personalized risk profile and disease management
plan. Many empirical researches have shown the great potential of personalized data-driven
prediction systems. Personalized modeling involves the similarity calculation and selection
of similar instances, thus sensitive to the choice of features, number of nearest neighbor
samples and distance metrics.[152] It’s reported that the inclusion of irrelevant features would
degrade the performance of personalized modeling[153], which emphasizes the importance
of feature selection from another angle. To guarantee the benefits from personalization,
we also need to choose appropriate similarity criteria and reach a good balance between
training data size and the degree of similarity. The commonly used similarity or dissimilarity
measures can be divided into two groups, that is, static metrics like Euclidean distance,
cosine distance[154, 155] and the learned metrics[35]. The determination of sample size of the
similar cohort is very critical and, it’s been shown that predictive performance can degrade
when the sample size of similar cohort is too small.[40]
Different distance metrics have been applied to the distance-based clustering methods,
like the k means, to evaluate their effect on clustering.[156, 157] The commonly used distance
metrics include Euclidean, Manhattan, cosine, Pearson correlation, city block distance, to
name a few.[158–160] Previous studies reveal that the best distance or similarity measure
is specific to clustering algorithm, the dimension of data and also the data types.[161–163]
A dynamic distance framework was proposed for this, called metric learning, and it has
been shown that the learned metrics on the local structure of data worked better than the
static distance.[35, 164] A previous study proposed four new distance-based classification
methods and compared their performance with that of the two well-known classifiers, k
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nearest neighbors (KNN) and the Parzen windows methods. L1 and L2 distance metrics were
used to measure the dissimilarity between points.[165] They compared the methods with




In this chapter, we propose a novel ensemble feature selection approach, named three-
stage feature selection to improve the adverse outcome prediction performance by selecting
informative features. After feature selection, we explore the use of survival analysis models to
predict hip fracture readmission and introduce the personalized modeling on adverse outcome
prediction.
3.1 Three-stage Feature Selection
In this section, a three-stage feature selection strategy is proposed, as shown in Figure
3.1. As stated earlier in this paper, each type of selection method included in this study
has its own strengths and limitations. It’s also noted that different selection methods may
select different feature subsets on the same data set.[166] To reduce this high variability, to
overcome the drawbacks of different methods, and to reduce the risk of overfitting are the
main goals of this new feature selection method. It consists of three successive steps: filter,
embedded and wrapper. Suppose that we have extracted the complete cases and they are split
into the training and test sets, the feature selection process will be applied on the training set
to select significant features and the selection result will be evaluated on the test set. The
proposed method first excludes the features that are not associated with the response using
filter methods. After this stage, hopefully the potential noise in the data will be removed,
resulting in a smaller number of explanatory variables, thus lower computation burden for
the next stage. Then it applies the embedded methods to select features that contribute
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most to the model accuracy by leveraging the structure of specific machine learning models.
At the end of this step, most of the falsely significant features selected in the filter step
are excluded. In the last wrapper step, we try to further reduce the feature space by the
leave-one-covariate-out (LOCO) approach, which is a model-free method to evaluate variable
importance.[167] This step also plays the role in testing the sufficiency of the first two steps.
The ideal situation is that the feature size won’t drop significantly from the second to the
third step.
Figure 3.1. Flowchart of the three-stage feature selection
3.1.1 Filter Selection
Since the embedded and wrapper methods are more computationally intensive, it
would be helpful if we can use filter methods to reduce the feature space first, and then use
the feature selection techniques that are more computation-demanding but more helpful for
improving prediction accuracy on the data. Here we use chi-square test to test the significance
of categorical variables, or Fisher exact test when at least one cell has the expected cell count
less than 5, and t test for continuous variables. The significant variables with p− value < 0.1
are selected for the next step. The filter step is a pre-screening of features to reduce the
computation burden in the steps that follow, thus we don’t want to miss any truly significant
features but can tolerate some false positive features since they can be identified in the next
two steps. That’s why we select 0.1 as the significance level rather than the more popular
0.05. In this stage, suppose that the original feature dimension is decreased from p to p1.
3.1.2 Embedded Selection
If the most non-informative features have been filtered out in the first step, the
computation burden of the second step will be largely reduced. Here we focus on two
embedded methods of different model structures: 1) Logistic regression with LASSO[118],
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which assumes additive structure and linear relationship, known for its good interpretability;
2) Gradient boosting machine (GBM)[168], which can deal with hierarchical structure and
nonlinear relationship. To eliminate the characteristics of data sets [41, 166], we apply each
ensemble method on 20 bootstrap samples. This step includes three sub-steps: firstly, we fit
each of the embedded models on the training set and rank features by importance values;
then we aggregate the feature rankings over the bootstrapped sub-samples and lastly we
estimate the minimal feature size for close-to-optimal accuracy using golden-section search[51]
together with the DeLong test[169]. The feature dimension is decreased from p1 to p2.
Feature ranking
The features are ranked by their importance value from each model, denoted by IV (j)
where i = 1, 2, . . . n.
• Logistic regression with LASSO
Denote the probability of adverse outcome for the ith patient by pi, then we have
yi ∼ Bernoulli(pi) (3.1)
We assume that there is a linear relationship between the predictors and the log-odds








where β0 is the intercept and βi’s are the coefficients for each of the p predictors. The












[yiµ(xi)− log(1 + exp(µ(xi))]
(3.3)
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[−l(β) + λβ1] (3.4)
For this model, we use the magnitude of the normalized coefficients to measure the
feature importance, i.e. IVLASSO(j) = | βj√∑
j∈1,2,..p1
β2j
| where βj is the coefficient of
feature j.
• Gradient Boosting Machine (GBM)
GBM is an ensemble of weak learners and we use decision tree as the base learner here.
Different from random forest, it iteratively builds additive models by sequentially fitting
a base learner to current “pseudo” residuals which are the negative gradient of the loss
function[168]. The process can be summarized as follows: Denote the loss function as
L(y, f(x)),
1. Initialize the model as f0(x) = c where c is a constant
2. Set the number of iterations as M . For each iteration m(m = 1, 2, . . .M), the
pseudo-residuals are computed as rim = −∂L(yi,fm−1(xi))∂fm−1(xi) for i = 1, 2, . . . , n.
3. Fit a base learner hm(x) to the pseudo-residuals
4. Compute the multiplier γm such that γm = argmin
∑n
i L(yi, fm−1(xi) + γhm(xi)).
5. Update the model: fm(x) = fm−1(x) + γhm(x)
6. After all iterations, output the final model
In case of the overcapacity of base learners, at each iteration it randomly select a
subsample of training data in place of the full sample to fit the learner.[170] For each
decision tree, at each node i except the leaf node, the node importance NIi is calculated
as the reduction in node purity from the split at this node; the feature importance FIj
is calculated as the sum of node importance split on feature j divided by the sum of all
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node importance.
NIi = wi ∗ Impurityi − wleft(i) ∗ Impurityleft(i) − wright(i) ∗ Impurityright(i)
FIj =
∑






wi = weighted number of samples at node i
left(i) or right(i) = child node from split on node i
pic is the frequency of label c at node i. The feature importance in GBM is the averaged




For both IVLASSO(j) and IVGBM(j) , the higher the value, the more important the
variable. Features are ranked by the importance value in descending order and the rank is
denoted as rj.
Ranking aggregation
Given a finite sample size, a small change in the data may result in big difference
in the feature selection of machine learning models, so we bootstrap the training data for
20 times and repeat the feature ranking sub-step to obtain feature importance rank from
different data samples. Then we aggregate the 20 feature rankings into a more stable ranking.
An extensive study[171] on comparing different rank aggregation techniques concluded that
different methods tend to be similar as the size of feature subset increases, so we use two
representative rank aggregation methods in this step: One is the simple average of the rank
from each bootstrap subsample and another is the weighted aggregation with the out-of-bag
validation AUC as the weight.














AUCOOB,b ∗ rbj (3.6)
Feature size estimation
Based on the aggregated feature ranking from the ranking aggregation sub-step, we
need to find the feature size kopt that achieves the highest AUC. Here we use the cross-
validated AUC to evaluate model performance. Since feature size k has its corresponding
AUC, the sequence of AUC for different k can be considered as a function of k, denoted by
f(k). To estimate the minimal size of features that can achieve close-to-optimal prediction
accuracy, we use the golden section search procedure, a search technique that can find the
maximum of a function over a specified interval. This algorithm searches for the maximum by
updating a triplet of points with specified updating criteria.[51] In this sub-step, we update
the triplet only when there will be significant change in the AUC and DeLong test is used to
test the difference between AUCs.(α = 0.05)
H0 : AUC1 = AUC2 v.s. H1 : AUC1 6= AUC2 (3.7)
In DeLong test, we first need to estimate AUC with Mann-Whitney statistic, which is a













1, if aTxi < a
Txj
0.5, if aTxi = a
Txj
0 otherwise
where D0 and D1 are the sets of control and case observations, respectively and ni is the
sample size (i = 0, 1). Then we can derive the test statistic as follows:
z =




p is the original number of features and k is the number of features removed. S is the
covariance matrix of (eAUCp, eAUCp−k). When the p− value of the test is smaller than 0.05,
we reject the null hypothesis, which states that there is no difference between the two AUCs.
3.1.3 Wrapper Selection
To further reduce the number of features, we apply the leave-one-covariate-out (LOCO)
method to test the significance of each remaining feature from embedded selection. LOCO
approach has the drawback of being computationally intensive when the feature size is large,
but the computation burden will be largely reduced after the filter and embedded step, which
is one reason why we put it in the last step. With the p2 selected features, we fit the model
and get the cross validated AUC (CV-AUC) of the training set, denoted by AUCf . Then
for each of the p2 features, we exclude it and retrain the model to calculate the CV-AUC.
It proceeds as follows, we exclude the jth feature and refit the model with the remaining
features and calculate the AUC as AUC−j. Then if AUCf > AUC−j, it means the inclusion
of feature j will improve the performance thus keeping this feature and removing it otherwise.
Logistic regression is used here to calculate the AUC for its computation efficiency. Figure
3.2 below shows the process of this step. It can also test the adequacy of embedded feature
selection by the drop of feature size after this step, that is, if the feature size doesn’t drop
significantly, we can tell that embedded step has reduced the feature size sufficiently.
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Figure 3.2. Flowchart of the wrapper selection
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3.2 Time-to-event prediction
For adverse outcome prediction problem like readmission, both the readmission
status and days to readmission are available. But the traditional practice in readmission
prediction often ignores the days-to-readmission and only builds classification model on the
readmission status, which may miss important information. Here we explore the possibility
of improving prediction performance by using both the status and time information. This
kind of time-to-event problem is usually treated as survival analysis problem. Suppose the
time-to-readmission is denoted by T, then T is the “survival” time and the survival function
is defined as S(t) = P (T > t). Suppose F (t) = 1− S(t) has the density function f(t) thus,
S(t)− S(t+ ∆t) = P{t ≤ T < t+ ∆t}
= f(t)∆t as ∆t→ 0
(3.9)










Another important concept is the hazard function defined as:
h(t) = lim
∆t→0










thus h(t) = f(t)
S(t)
. There are three classical survival distributions often used as the distribu-
tion of survival time T, i.e. Weibull distribution, exponential distribution and log-logistic
26
distribution. [37] And we can derive the survival function and hazard function in Table 3.1:
Table 3.1. The survival, density and hazard function of Weibull, Exponential and Log-logistic distribution
Distribution S(t) f(t) h(t)
Weibull(λ, p) exp(−λtp) λptp−1 exp(−λtp) λptp−1







The above survival processes are also called the baseline survival function since the
effect of covariates on the survival status is not considered. To study the effect of covariates
on the survival time, there are two classical survival models based on different assumptions.
The first type is the family of accelerated failure time (AFT) models[172], which
assumes that the covariates act as acceleration factors to speed up or slow down the survival
process compared with the baseline survival function. Suppose we have the feature vector
x = (x1, x2, . . . , xp) and the baseline survival time T0, then the assumption is T = exp(β
Tx)T0
and exp(βTx) is also called the acceleration factor, thus the process is speed up if exp(βTx) > 1
and slowed down otherwise. With each of the three classical survival distributions above[173]
as baseline function S0(t), we can derive three types of AFT model:
• Weibull AFT model
Given x, we can derive conditional survival distribution of T ,
S(t|x) = P (T > t|x)
= P (exp(βTx)T0 > t|x)

















• Exponential AFT model





where λ1 = λ exp(−βTx)
(3.14)
• Log-logistic AFT model
Same as before, let k = 1
σ














If we add an intercept term in β then, x = (1, x1, x2, . . . , xp) and λ, θ in Equation 3.12 - 3.15
can be combined into β. Thus the parameters need to estimate are β and σ, which can be
solved with partial likelihood method[174] and Newton Raphson (NR) algorithm.
The second type is the Proportional Hazard (PH) model, which assumes that the
covariates execute their effect on the hazard rate rather than on the survival time directly,
that is, h(t) = exp(βTx)h0(t). For different baseline survival distribution, we can derive the
survival function in the same way as before and estimate the parameters with NR method.
Cox proportional hazards model[136] is an approach that can estimate the effect parameter
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without considering the hazard function.


















where H0(t) is the cumulative hazard function and can be estimated with the Breslow’s
method.[175]
Both of the AFT model and Cox proportional hazards (Cox PH) model assume that
each subject will eventually experience the event of interest, given enough follow-up time. But
for the readmission prediction problems, there may be some exceptions, like some patients
may never get readmitted. In other words, there should be a “cure” fraction in the population,
and the mixture cure model[176, 177] is motivated for this need. It not only involves modeling
the survival distribution of the uncured patients but also the cure rate.[139] The mixture
cure model can be expressed as follows:
S(t|x, z) = π(z)S(t|Y = 1, x) + (1− π(z)) (3.17)
where S(t|x, z) is the conditional survival function of the entire population and Y is the
indicator of whether the patient will experience the event eventually.(Y = 1 if the patient will
experience it and Y = 0 if not). S(t|Y = 1, x) is the conditional survival function of those
susceptible to experience the event and in this study we use the Cox proportional hazards
model to describe their survival distribution.
S(t|Y = 1, x) = exp(− exp(βTx)H0(t)) (3.18)
The incidence portion is often modeled using the logit link function, where z is the
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Here we will use the same set of features to fit the logistic regression and survival
function, that is, z = x. Since the information of the indicator Y is not complete, an itera-
tive approach like the expectation maximization (EM) algorithm is used for the parameter
estimation thus the mixture cure is more computation-demanding. We will explore the use
of the mixture cure model on adverse outcome prediction. For comparison, we will also
use Cox PH and AFT model to predict readmission and test the significance of includ-
ing cure fraction. The R-package survival[178] is used for AFT and Cox PH model and
smcure[139] is for mixed cure model. For this time-to-event prediction problem, we will use
the 30-day hip fracture readmission prediction as an example. When evaluating or compar-
ing the performance, we will use the AUC at the time point of 30 days as the evaluation metric.
For survival analysis, we need to define the time-to-readmission and censoring status
first. Time-to-readmission is defined as the number of days from the index hospital discharge
to the first readmission before the date of data collection. And cases are censored if the
patients don’t get readmitted before the data collection date. In this study, we aim to improve
prediction performance by integrating the time-to-readmission with survival analysis.
3.3 Steps for Personalized Predictive Modeling
To better capture the unique characteristics of individual patients as well as improve
the prediction accuracy, we introduce the personalized modeling to adverse outcome prediction.
The key idea of personalized modeling is to identify the most similar patients and fit a separate
model to make prediction for each individual patient. It involves four steps: 1) Selection
of features and similarity measurement; 2) Extraction of similar patients; 3) Predictive
modeling; 4) Personalized risk factor profile building. Details of each step are discussed in
each sub-section as follows.
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3.3.1 Selection of features and similarity measurement
We first need to select a set of features for both similarity calculation and predictive
modeling. Then with the selected set of features, we explore the effect of different similarity
metrics on the predictive performance.
• Select a subset of features to measure the similarity among patients
A survey on case based reasoning discussed about the top issues in deriving individual
based models in medical field.[179] They pointed out that a representative and compre-
hensive case library is the key to the good model performance. In our study, EHRs
database can help to solve this issue with large amount of various patient information.
Another limitation of person based learning is the need of expert knowledge for feature
selection and weighting. Our proposed feature selection is a perfect fit for this need.
To ensure that only significant features are included when measuring patient similarity
and reduce the burden of computation, we will use the final feature set selected by the
proposed three-stage feature selection method.
• Select a static similarity measure or learn it by supervised metric learning
The similarity and dissimilarity measures are important in clustering and classifica-
tion analysis. [35, 180, 181] Various methods of measuring similarity among individ-
uals have been extensively used in different fields, like biology, ecology and image
recognition.[158–160] Some examples of similarity measures are listed in Table 3.2.
Different similarity measures can be used to identify cohort of patients from the training
set that are most similar to the test patient. The similarity function is often defined
as Similarity(x, y) = −f(x, y) where f is the distance function and the instances are





j=1(xi − yi)2 and is
often used for numeric-valued attributes
In different clinical scenarios, we may require different similarity metrics rather a
single static measure like Euclidean distance.[35, 185] For example, patients that are
similar to each other with respect to one disease, e.g. heart failure, may not be similar
for a different disease such as diabetes. One remedy to this is the distance metric
learning techniques, like Locally Supervised Metric Learning (LSML)[186] and Large
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Table 3.2. Examples of Similarity Measures
Category Distance/Similarity Examples
Static Distance
General Euclidean; Cosine; Manhattan[35]
Binary vector Jaccard index; Tanimoto; Roger and
Tanimoto[160]
Learned Distance
Supervised Locally Supervised Metric Learning[177];
Sparse Distance Metric Learning[182]; Large
Margin Nearest Neighbor(LMNN)[183]
Unsupervised Covariance metric[184]
Margin Nearest Neighbor Classification (LMNN) [187], which can be trained for specific
clinical condition. Many researches have shown that learning a distance metric can
significantly improve the classification accuracy.[187–189] Distance metric learning is
done by learning a transformation matrix W from the training data and then the
distance metric between any two observations (xi, yi) and (xj, yj), is defined as follows:
DML =
√
(xi − xj)TWW T (xi − xj) (3.20)
The trainable metric is customized for the problem setting thus satisfying the require-
ment that different clinical scenarios need different similarity metrics to measure how
similar two patients are. For example, LMNN learns the transformation matrix as a
neighborhood margin maximization problem which tries to keep the close k-nearest
neighbors from the same class, while keeping examples from different classes separated






DML(xi, xj) + λ
∑
i,j∈Ni,l,yl 6=yi




(xi − xj)TWW T (xi − xj) (3.22)
and Ni is the set of exactly k different nearest neighbors with label yi under the learned
metric, [a]+ = max(a, 0) and W ≥ 0.
32
In our study, we will compare the performance of personalized modeling with the
Euclidean distance, cosine distance, LMNN and random selection.
3.3.2 Extraction of similar patients
Prior to similarity calculation, all continuous predictors are normalized to fit the range
between 0 and 1. For each categorical predictor, we convert them into dummy variables. For
any new patient, we compute their distance to all the patients in the training set and rank
the training patients by the distance in ascending order. The top K patients are selected
to form the similar patient cohort. K is a tuning parameter that can be chosen by cross
validation. The selection of similar patients can be done in two ways: one is not considering
the outcome occurrence rate of the training patients so the resulting similar patient cohort
may not maintain the case-control balance; another is to select similar case and control
patients separately and then combine them into one cohort to control the case-control balance.
For simplicity, here we do not consider the case-control balance.
3.3.3 Predictive modeling
Once the personalized training cohorts are identified, any supervised classification or
regression method can be used to fit the model and make prediction on the test patient. We
use logistic regression as the predictive model here because it is not only interpretable but
also produces risk probability. With the predictions for each test patient, we can combine
them into a prediction vector and calculate the performance metric AUC to evaluate the
prediction performance.
3.3.4 Building personalized risk factor profile
The personalized model can reveal the specific association of each factor to patients
on the individual basis. From the logistic regression model, we can get the beta coefficient for
each factor and also their significance level. And the factors with large coefficient value and
significant test result are important risk factors, which can be used to build risk factor profile.
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With the individualized risk factor profile, individual-based care management plan can be pro-
vided to patients, thus contributing to the better interactions between physicians and patients.
3.4 Applications
In this study, we will extract the study populations from the Cerner Health Facts
EHR database (Cerner Corporation, Kansas City, MO). The data include time-stamped
admission, diagnosis, laboratory, surgical, and medication information and are de-identified
in compliance with Health Insurance Portability and Accountability Act (HIPPA). In pursuit
of our goal of improve adverse outcome prediction with EHRs data, the proposed feature
selection and model development, we will apply our proposed methods to two example adverse
outcome prediction problems: one is the 30-day hip fracture (HF) readmission and the other
is the diabetic retinopathy(DR) prognosis.
These two datasets are chosen for three reasons: The first reason is their clinical
significance. Hip fracture readmission not only increases patients mortality rate but also
brings big economic burden to both hospitals and patients [4, 191] and diabetic retinopathy
is the leading cause of blindness in American adults.[7] However, compared with diseases
and conditions like heart failure, heart attack and chronic obstructive pulmonary disease
(COPD), the prediction problems of these two diseases are less studied.[10] The second reason
is because they have different data properties; The HF data has much more features than the
DR data and all features in the HF data are categorical or binary while most features in DR
data are numeric. Lastly, the performance of prediction models on different adverse outcomes
often varies widely, and it’s often better on prognosis of diseases while worse on readmission.
[20] The proposed methods can be better evaluated with data of different prediction difficulty.
And the studies of these two questions have different application scenarios: the prediction of
hip fracture readmission is more classification-oriented and tends to be used for patient risk
stratification while the prognosis of diabetic retinopathy is for the purpose of preventing DR
from happening.
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3.4.1 30-day Hip Fracture Readmission
Hip fracture diagnoses and surgeries were identified using the International Classifica-
tion of Diseases, 9th Revision - Clinical Modification (ICD-9-CM) diagnosis and procedure
codes listed in Table 3.3. A patient’s index admission is defined as an admission with one
or more 820.xx hip fracture diagnoses as the primary or secondary conditions (priority ≤
2) and at least one procedure coded as 79.15, 79.35, and 81.52. In this study, we will focus
on the patients discharged between January 2006 and August 2015. A total of 38,981 index
admissions with associated diagnosis and procedure code for hip fracture surgery are eligible
for this study. Based on the exclusion rules defined in Figure 3.3, we end up with 35,561
index admissions as our study population. Since only 3.1% of the patients have more than
one index admissions, we assume all the index admissions are independent. A readmission is
defined as a subsequent all-cause inpatient admission in the same or a different hospital within
30 days following an index admission. We labelled each index admission by “readmitted” or
“non-readmitted” based on whether they were re-hospitalized for any reason within 30-days
of discharge from the index admission.
ICD-9-CM code Description
820.xx Fracture of neck of femur (hip)
79.15 Closed reduction of fracture with internal fixation; femur
79.35 Open reduction of fracture with internal fixation; femur
81.52 Partial hip replacement
Table 3.3. ICD-9-CM codes used to identify hip fracture diagnoses and surgeries
Although hospital system characteristics, such as the bed size, also influence the readmission
rate, it should not affect the quality of care[192]. Therefore, our study doesn’t include such
hospital characteristics. The predictor variables examined in this study can be grouped into
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Figure 3.3. Cohort derivation of 30-day hip fracture readmission
six categories:
• Demographics, e.g. age, race, gender and marital status
• Encounter-related variables, e.g. discharge location and length of stay
• Comorbidities and Charlson Comorbidity Index[193]
• Procedures and diagnosis
• Lab tests
• Hospital utilization: the number of hospital visits (inpatient or emergency room (ER))
during six months/one year prior to the index admission
The diagnoses and procedures were classified based on the Clinical Classifications
Software (CCS) available from the Agency for Healthcare Research and Quality. The Charlson
Comorbidity Index is calculated based on the diagnoses recorded during the stay of each
admission using the algorithm presented in[194]. There is also research showing that previous
admission to hospitals is a robust predictor of future hospitalization.[195] In this study,
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we construct hospital utilization features by aggregating patients’ previous inpatient and
emergency room visits. The number of prior inpatient / emergency room (ER) visits is
counted based on inpatient / ER encounters during the past 3 months / 6 months / 1
year prior to the index admission. All the continuous variables are discretized into nominal
variables since we check that there is no significant difference between the performance of their
continuous and categorical version, but the discretized data is relatively easier to interpret
from the clinical point of view. After discretization and dummy encoding, there are 534
features in total and the readmission rate is 11%.
3.4.2 Diabetic Retinopathy Prognosis
The diagnosis of diabetic retinopathy is identified by the International Classification
of Diseases – Ninth Revision (ICD-9) codes as shown in Table 3.4. We firstly extract
diabetic patients who have one or more 250.xx ICD-9-CM diabetes codes. Then based on
the appearance of diabetic retinopathy (DR) diagnosis code 362.0x ICD-9-CM, patients were
labelled by either “DR” or “non-DR”. A total of 52,375 patients are selected to form the final




Table 3.4. ICD-9-CM codes used to identify diabetic retinopathy diagnoses
Based on the literature on diabetic retinopathy prediction, we selected features that
have shown statistically significant association with the onset of diabetic retinopathy. A
total of 32 predictor variables were included in this study and they were grouped into two
37
categories:
• Demographics: age, race and gender
• Lab results: HbA1c, blood urea nitrogen (BUN), creatinine, glucose, hemoglobin, hema-
tocrit, calcium, triglyceride, potassium, chloride, mean corpuscular hemoglobin (MCH),
sodium, mean corpuscular hemoglobin concentration (MCHC), mean corpuscular vol-
ume (MCV), albumin, bilirubin, protein, anion gap, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase (ALP), high-density lipoprotein
(HDL), red blood cell count (RBC), white blood cell count (WBC), platelet, cholesterol,





4.1.1 30-day Hip Fracture Readmission
Figure 4.1. Data split for hip fracture readmission dataset
After the discretization of continuous features and dummy encoding of categorical
features, we ended up with 534 features, all of which are encoded as 0/1 features. The common
practice of prognostic research is training the model in the past and making predictions in the
future[196], thus we split the data based on the discharge date of the index admission. The
whole dataset is split into the training set and test set, with January 2015 as the cut point.
91% of the admissions have discharge date prior to January 2015 and they build the training
set, and the remaining 9% form the test set. So the model is trained on the past patient
records and validated with patients new to the system.[197] The readmission rate of the
whole patient cohort is 11% while the rates for the training and test set are 11.16% and 9.48%
respectively. Demographic characteristics of the patient population are presented in Table
4.1. We can observe some difference in the distribution of both the covariates and response










Readmitted (%) 11.16 9.48
Age (%)
[50, 65) 9.72 11.68
[65, 75) 14.76 15.17
[75, 80) 13.37 12.98
[80, 85) 20.35 18.74
[85, 90) 23.23 21.86
[90, 100] 18.57 19.57
Male (%) 27.66 29.24
Race (%)




Table 4.1. Patient demographic characteristics of training and test sets – 30-day hip fracture readmission
We applied the proposed three-stage feature selection method on the training set
to select the most predictive features. In the filter selection step, the chi-square test or
Fisher exact test is used to test the univariate significance of each feature and 148 out of
534 are selected (p− value < 0.1). The remaining features are input into the embedded and
wrapper selection step and the feature size change are depicted in Figure 4.2. On the left
is the selection with Gradient Boosting Machine (GBM) as the embedded method and on
the right is with Logistic regression (LR) with LASSO as the embedded method. Different
color is used to denote the results from the two ranking aggregation methods: orange is for
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the simple average of ranking(denoted by ”Mean rank” in the legend) and blue is for the
weighted average of ranking(denoted by ”Wt Mean rank” in the legend).
Figure 4.2. Number of selected features after each step – hip fracture readmission. On the left is the
selection with Gradient Boosting Machine (GBM) as the embedded method and on the right is with Logistic
regression (LR) with LASSO as the embedded method.
In both plots, there is a big drop in the feature size from the filter step to the embedded
step for both ranking aggregation methods, indicating that there are still some falsely sig-
nificant features remaining after the filter selection. But the filter step largely reduced the
computation burden of embedded selection compared to staring with all 534 features. The
two embedded methods reduce the feature size to different degrees and overall the GBM
has a higher reduction in feature size than LR with LASSO. For the embedded selection
with GBM, the weighted average of ranking ends in a much smaller set of features than the
simple average of ranking. For LR with LASSO, the two ranking aggregation methods lead
to similar feature size reduction. Features from the embedded step are then put into the
wrapper step, which plays two roles: one is to reduce the feature size and the other is to
detect whether the embedded selection is sufficient. For the GBM scenario, the feature set
from the simple average of ranking is further reduced by half while that from the weighted
average of ranking is just reduced by 1. The wrapper step seems to be more necessary for the
simple average of ranking than the weighted average of ranking. This indicates that for the
GBM embedded selection, the weighted average of ranking is more robust than the simple
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average. For the LR scenario, there is a big reduction in the feature size of both ranking
aggregation methods, which indicates that LASSO doesn’t reduce the feature size efficiently
for either ranking aggregation method.
To fairly compare the performance of both methods, we should look at not only the
size of selected features but also the prediction performance of the final feature set, thus we fit
the logistic regression on the four selected feature sets as well as the original set to calculate
the test AUC. Figure 4.3 shows the number of features and the test AUC of each feature
set. The overall performance of the GBM scenario is better than the LR, which is in line
with out expectations since GBM is more hypothesis-free and can capture the more complex
non-linear structure in data. For the selection with GBM, compared with the simple average
of ranking, the feature set selected from the weighted average of ranking performs better with
higher test AUC and smaller size, which makes sense since it aggregated the feature rankings
from 20 bootstrapped samples by taking weighted average of the rankings with the out-of-bag
(OOB) AUC as weight. Compared with the 534 features in original feature set, the feature
set from the weighted average of ranking selects only 14 features but reaches 98.37% of the
original test AUC.
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Figure 4.3. Test AUC based on different feature sets. The left plot is from the feature sets selected by GBM
and the right from LR with LASSO. In both plots, the x axis represents the feature sets and the primary
and secondary y axis respectively represents the number of features (right) and the test AUC (left).
GBM seems to benefit more from feature ensemble and outperforms LASSO with a
higher accuracy and better stability. Among the 14 features selected by the ”best” selection
scenario (GBM with the weighted average of ranking), half of them are related to the lab tests
and diagnosis. Some features are known risk factors of readmission, including age, gender
and length of stay. Some less widely investigated features like previous inpatient visits and
discharge location are also identified.
4.1.2 Diabetic Retinopathy
Figure 4.4. Data split for diabetic retinopathy prognosis dataset
Since diabetic retinopathy can be prevented with early treatment, we need to make
early detection before the diagnosis. This means that we need to use information from
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much earlier stage to make prediction and suggest prevention treatment. There are two
terms involved in the data collection: 1) Prediction window, which is the time window
before the diagnosis that the disease is detected. 2) Observation window, which is the
time window before the prediction window from which the data are collected for use.[79]
In this research we chose two years for the observation window and six months for the
prediction window. As shown in Figure 4.4, the response label of patients are obtained on
the diagnosis date but the predictors are aggregated over the 2-year-long observation window.
The whole cohort is split into training and test sets with random selection in the ratio of 7 to 3.
The lab tests selected for this research are all numerical variables, including counts
and continuous measurements. It’s hard to find reasonable cut points to discretize all of
them. Thus, in this research, we would not discretize the numerical features but kept their
original form, and the same for the age variable. Table 4.2 include the patient demographic
characteristics in the training and test set and we can observe that the training and test sets









DR (%) 4.18 3.91





Male (%) 45.30 45.73
Race (%)
African American 16.65 16.45
Caucasian 74.83 75.22
Other 8.52 8.33
Table 4.2. Patient demographic characteristics of training and test sets – diabetic retinopathy prognosis
Then we applied the three-stage feature selection method on the training set to find
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the smallest significant feature subset. In the filter selection step, the chi-square test and t
test are used to test the univariate significance of each feature and 25 out of 32 are selected
(p− value < 0.1). We put the remaining features into the embedded and wrapper selection
step and the feature size change are depicted in Figure 4.5. On the left is the selection with
GBM as the embedded method and on the right is with Logistic regression (LR) with LASSO
as the embedded method. Different color corresponds to the two ranking aggregation methods:
orange for the simple average of ranking and blue for the weighted average of ranking. For the
GBM scenario, we can observe that, after the embedded step, the two ranking aggregation
methods had the same drop in the feature number. Thus we compared the selected feature
set from both methods and found that although they selected the same number of features,
there is one feature different between the two sets. Features from the embedded step are then
put into the wrapper selection. Figure 4.5 shows that even starting with the same number
of features, the two aggregation methods ended up in different number of features after the
wrapper step. Feature set from the simple average of ranking is reduced by 2 while that
from weighted average of ranking is reduced by 4, and it may indicate that the latter one
can identify more falsely significant features from the embedded step, which is also proved
by the AUCs in Figure 4.6. The selected features are put in the Appendix for reference
and comparison. For the LASSO scenario, the two ranking aggregation methods show no
difference in the feature reduction of embedded step and thus ending the same feature set
after wrapper step. The feature size drops significantly from 25 of the filter step to 6 of the
embedded step and no drop from the embedded step to the wrapper step. By comparing the
two final selected feature sets in LASSO scenario, we found that the two ranking aggregation
methods have selected the same set of features.
Same as before, we calculated the test AUC of logistic regression fit on the two selected
feature sets and the original set. Figure 4.6 shows the number of features and test AUC of
each feature set. Still, the overall performance of GBM is better than LASSO. For the former
scenario, compared with the simple average of ranking, the features selected by the weighted
average of ranking performed better, with higher test AUC and smaller feature size. The test
AUC of features from the weighted average of ranking is about 98.19% of the AUC on the
original feature set while its feature size is just 40.6% of the original size.
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Figure 4.5. Number of features selected after each step - diabetic retinopathy prognosis. On the left is the
selection with GBM as the embedded method and on the right is with Logistic regression (LR) with LASSO
as the embedded method.
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Figure 4.6. Test AUC based on different feature sets. The left plot is from the feature sets selected by GBM
and the right from LR with LASSO. In both plots, the x axis represents the feature sets and the primary
and secondary y axis respectively represents the number of features (right) and the test AUC (left).
By comparing the feature selection result of hip fracture readmission and diabetic
retinopathy prognosis, GBM outperforms LASSO with reasonable feature size and higher
prediction accuracy. We can observe that under the GBM scenario, for both datasets, the
weighted average of ranking achieves the best performance since it selected less than half
of both original feature sets but the prediction accuracy is about the same as the original
feature sets. But there is also difference in their magnitude of feature reduction. Potential
reasons for this include:
• The predictive power of the original features. It’s easy to tell that compared with the
HF data, the original DR data has a smaller number of features but there are more
predictive features to the response variable. It also means that the HF data contains
more insignificant features than DR data. That’s why the feature size reduction of
DR data is smaller than that of HF data but the overall performance of DR data is in
higher level.
• The population shift problem. The way that the two datasets are split into the training
and test sets is different, one is by time and the other is by random selection. This
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partially explains the poor performance of the HF model on the test set.
4.2 Prediction with the time-to-event
For each admission of patients to hospital, there are two important time points, the
admission date and the discharge date. If we use the readmission date to minus the discharge
date of the index admission, we will get the days-to-readmission. If the days-to-readmission
is less than or equal to 30 days, it also means that patients get readmitted within 30 days.
Although classification models are often used to predict patients’ 30-day readmission status,
in this part we converted it into a time-to-event problem and use survival analysis to predict
the status. Since it’s hard to define a meaningful term like “days-to-readmission” for dia-
betic retinopathy prognosis problem, we only use the hip fracture data as example in this part.
Here we used the same training and test sets as in the feature selection experiment.
The training set is used to fit the model and the test set is used for evaluation. Since the
ubiquitous evaluation metric in readmission prediction modeling is AUC. And AUC can be
computed for survival analysis at any timepoint of the survival curve.[198] In this research,
we calculated AUC for the test set at day 30, day 60 and day 90, as listed in Table 4.3.[199]
Method/AUC
Mean rank Weighted mean rank
30 60 90 30 60 90
AFT Weibull 0.5929 0.5908 0.5897 0.6011 0.5986 0.5982
AFT Exponential 0.5995 0.5971 0.5967 0.5993 0.5973 0.5962
AFT Log-logistic 0.5932 0.5910 0.5998 0.6009 0.5985 0.5981
Cox PH 0.5900 0.5881 0.5867 0.6006 0.5981 0.5981
Mixture cure 0.5908 0.5888 0.5873 0.6007 0.5982 0.5981
Table 4.3. Test AUC for different methods, at three timepoints, day 30/60/90
Since our goal in this part is to compare the performance of classification model and
time-to-event prediction model and the computation would be much slower with the original
set of features, we trained each model with the two selected final feature sets from the GBM
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scenario. We can observe that overall, features selected by the weighted average of ranking
outperformed features from the simple average of ranking. For each set of features, the family
of AFT models performs slightly better than others but there is no significant difference
among different models. And it’s unexpected that the mixture cure model doesn’t outperform
the others.
Although survival analysis doesn’t significantly outperform the logistic regression, it
does provide flexible and dynamic analysis on patient risk status. With survival analysis,
we can predict the probability of an adverse outcome at any time point rather than at a
certain time point. So we are able to extend the classification problem to any time point we
are interested in. For example, for readmission prediction problem, the time window used
to define readmission has long been a controversial topic, like 15-day, 30-day, 60-day and
90-day.[130] With the time-to-event model, we can make readmission prediction at any time
point with one single model rather than fitting one classification model for each of the time
windows of interest.
4.3 Personalized Modeling (PM)
In this part, for the sake of computation, we used the features selected by the ”best”
combination, i.e. GBM with the weighted average of ranking aggregation method from
previous result part. To study the effect of the number of nearest neighbor training patients
(K) and the distance metrics on the prediction performance, we chose a set of candidate
values for each of them and repeated the same personalized modeling steps. For the choice of
K, we need to set it big enough to make sure the inclusion of observations from both the
majority and minority class. Since the degree of imbalance problem and total observation
number of the two datasets are different, the selected candidate values for K are a little
different for them. For the distance metrics, we chose four candidate metrics, including 1)
two static distance metrics – Euclidean distance, cosine distance; 2) two metrics from metric
learning – LMNN + Euclidean distance; LMNN + cosine distance. Below are the detailed
setting and results on the two datasets.
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4.3.1 30-day Hip Fracture Readmission
We selected nine values for K, including 100, 500, 1000, 3000, 5000, 7000, 9000, 10000
and 15000 and plotted the performance of the personalized logistic regression as a function of
K as shown in Figure 4.7. And there are five different distance configurations denoted by
curves of different colors and labels. Additionally, we put the performance of global logistic
regression model (◦) in the same plot as reference and need to note that it’s trained with the
whole training set and does not change with the size K. Firstly, as a baseline, K training
Figure 4.7. Performance of the personalized logistic regression model in terms of AUC as a function of K
– hip fracture readmission
patients are randomly selected to train the personalized model (∗). Its performance keeps
increasing as the number of training patients increases and almost levels off after K=3000.
With slightly increase, it reaches the performance of global model around K=8000. The
steady increase before K=3000 is reasonable since the training of logistic regression requires
enough data. And when the data size is big enough, more training observations won’t
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contribute much to its performance, and that’s why there is just minor increase after this
point. Then, instead of selecting the patients randomly, we used static distance metrics, the
Euclidean distance () and the cosine distance (), to select the K most similar patients
for model training. For both of them, the performance is consistently better than the
random selection, especially when K is small. This indicates the gain of using the more
similar patients compared with the randomly selected patients. Their performance keeps
increasing but starts to level off after K=3000, which implies that the inclusion of more
dissimilar patients won’t improve the performance. For cosine distance, there is even a minor
decrease with more dissimilar patients included into model training. Lastly, we used the
LMNN version of both distance metrics to select the most similar patients (× and 4). But
there is no significant difference between the static measure and the trained measure for
different values of K. Overall, the Euclidean distance performs slightly better than the others.
We also analyze the characteristics and distribution of the patient-specific risk fac-
tors with clustering analysis to prove the need of personalized predictive modeling. We
randomly select 200 test patients and extract the coefficients of the risk factors when K=3000.
Agglomerative hierarchical clustering is used here to cluster the risk factors and patients
respectively and the cluster tree is shown in Figure 4.8.The rows are the risk factors and are
clustered along the vertical axis. The columns stand for the risk factor profile of each patient
and are clustered along the horizontal axis. The patient 30-day readmission status is also
plotted as a horizontal bar on the top; green stands for non-readmitted and red stands for
readmitted. Different colors are used to represent the coefficient values of the risk factors
in the heat map: red means high and blue means low. Based on the risk factor profile (i.e.
columns), similar patients are clustered together while those with very different risk factor
profiles are put into clusters that are further away from each other. Patients with the same
readmission status can have very different risk factor profile. For example, the patients with
30-day readmission are scattered in different clusters. For different patients, the same risk fac-
tor may exert effect on them in different directions, which the global model may fail to capture.
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Figure 4.8. Hierarchical heat map plot of the risk factors from the personalized predictive models for 200
randomly selected test patients - Hip fracture readmission. The rows are the risk factors and are clustered
along the vertical axis. Each column stands for a patient and the red-green horizontal bar on the top stands
for their 30-day readmission status.(Green: Non-readmitted; Red: Readmitted.)
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4.3.2 Diabetic Retinopathy prognosis
Compared with the hip fracture readmission data, diabetic retinopathy has a much
lower occurrence rate. When we set K to be 100 or 500, sometimes the selected nearest
neighbor training patient cohort doesn’t contain any positive cases. Thus, we need to set K to
be big enough and here we selected eight values for K, including 1000, 3000, 5000, 7000, 9000,
10000, 15000 and 20000. The performance of the personalized logistic regression as a function
of K is shown in Figure 4.9. Other configurations are the same as in the previous experiment.
Here we can observe the same patterns of how the performance change with the increase of
K as before. But one big difference is the significantly better performance of personalized
modeling over the global model and random selection for all values of K, compared with
result of the hip fracture readmission. This is because, here K starts from 1000 and we are
not able to see the performance when K is smaller as before. And for this dataset, the cosine
distance and its trained distance perform better than the Euclidean distance.
Same as before, we also analyze the characteristics and distribution of the patient-
specific risk factors with clustering analysis and plot the heat map of the coefficient values
of risk factors in Figure 4.10. Here we randomly select 200 test patients and extract the
coefficients of the risk factors when K=7000. The horizontal bar on the top stands for whether
the patient is diagnosed of diabetic retinopathy on the diagnosis date; green stands for no and
red stands for yes. Patients with the same diagnosis status can have very different risk factor
profile and are scattered in different clusters, indicating the need for personalized predictive
modeling.
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Figure 4.9. Performance of the personalized logistic regression model in terms of AUC as a function of K
– diabetic retinopathy prognosis
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Figure 4.10. Hierarchical heat map plot of the risk factors from the personalized predictive models for 200
randomly selected test patients - Diabetic retinopathy prognosis. The rows are the risk factors and they are
clustered along the vertical axis. Each column stands for a patient and the red-green horizontal bar on the




In this thesis, we try to improve the adverse outcome prediction from two aspects,
the feature selection and model development. We propose an ensemble feature selection
method and explore the use of survival analysis methods and personalized modeling on
adverse outcome prediction. While we exemplify the application of our methods with specific
research questions, they can be applied to various disease targets and outcome types.
5.1 Feature selection
We have developed a stable feature selection framework that can learn from the data
and select features automatically. The criteria of defining a good feature selection method
should include both accuracy and stability. Accuracy measures the predictive power and
reliability of the final feature set in clinical applications and stability ensures the insensitivity
to over-fitting of the result. To improve prediction performance, we include the embedded and
wrapper methods in the selection process and use accuracy as the updating criterion in the
search algorithm. We strengthen the stability of the selection method by combining different
feature selection techniques[126] and using bootstrapping to aggregate the selected feature
subsets[41] to reduce the variance when selecting features on different data subsets. GBM
seems to outperform LASSO in selecting and ranking the features with more accuracy-related
importance values. Feature ranking aggregation is crucial to improving accuracy and stability
of the selection result and the result shows that the weighted aggregation method performs
better than the simple aggregation, with fewer features and higher accuracy.
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For hip fracture readmission, the best feature set has 14 features, most of which are
lab tests and diagnoses. Some features are the known predictors of hip fracture readmission,
like age, gender and length of stay. For diabetic retinopathy prognosis, we have identified 12
vital signs and age as the most important risk factors. We need to note that the prediction
performance of hip fracture readmission is pretty modest compared with that of the diabetic
retinopathy. Since the data types of features in these two datasets are different, we are
interested in studying the effect of data types on predictive power. As the stability of feature
selection technique is gaining more importance, a consensus stability measure also needs to
be developed for fair comparison of feature selection methods.
5.2 Time-to-event Prediction
In this study, we investigate the performance of several survival analysis methods on
the 30-day hip fracture readmission prediction. It’s shown that the family of AFT models all
perform well and slightly outperforms the other methods. The mixture cure model does not
seem to meet the expectations, although it has the advantage of not assuming the survival
function will go to zero when time goes to infinity. Compared with binary classifiers, the
time-to-event prediction achieves similar performance but provides more flexibility on the
dynamic analysis of patients’ status. With only one survival analysis model, we are able to
predict the patients’ readmission status over different time frames.
The performance of the mixture cure model is sensitive to the cure fraction and
previous simulation study showed that the convergence of cure model gets more difficult as
the cure fraction decreases to zero.[200] This is a possible reason for the modest performance
of mixture model in comparison with AFT and Cox regression models. Further investigations
on other patient data sets with higher cure fraction are necessary for uncovering the reason
behind this.
In the medical context, people are concerned about more than one type of adverse
outcomes. For example, a patient may have the risk of developing new diseases, readmission
and mortality at the same time. In the future, we can extend the one-type adverse outcome




In this part, we use empirical study to show the potential of personalizing patients’
status prediction by identifying and analyzing their past similar patients. By exploiting
similarity analytics, personalized predictive model trained on a smaller set of clinically similar
patients can perform better than the global model fit on all available data. Personalized models
can also identify the important risk factors on an individual basis and provide customized
decision support for doctors. Our experiment also characterizes the trade-off between the
training set size and the degree of similarity between the training cohort and the test patient
for whom we are making the prediction, as concluded in [40]. And the performance of
personalized modeling also depends on the data types and the actual predictive power of the
features.
There are some directions for future work. Firstly, the approach need to be validated
on additional research questions and more datasets. Secondly, the accurate identification of
clinically similar patients is a crucial step to the prediction performance thus selecting an
appropriate similarity measure is of great importance. We can investigate the relationship
between data types and similarity measures to choose the most suitable one based on the
data types, disease target and so on. We can also replace the logistic regression with more
sophisticated classification algorithms as the prediction model. Lastly, since both of the
adverse outcome problems discussed in this study have binary response variable, we may
extend the personalized modeling to continuous response variables to test its effectiveness.
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participant similarity for the classification of epidemiological data on hepatic steatosis.
In 2014 IEEE 27th International Symposium on Computer-Based Medical Systems,
pages 1–7. IEEE, 2014.
[182] Fei Wang and Jimeng Sun. Survey on distance metric learning and dimensionality
reduction in data mining. Data mining and knowledge discovery, 29(2):534–564, 2015.
78
[183] Kilian Q Weinberger, John Blitzer, and Lawrence K Saul. Distance metric learning
for large margin nearest neighbor classification. In Advances in neural information
processing systems, pages 1473–1480, 2006.
[184] Bo Wang, Jiayan Jiang, Wei Wang, Zhi-Hua Zhou, and Zhuowen Tu. Unsupervised
metric fusion by cross diffusion. In 2012 IEEE Conference on Computer Vision and
Pattern Recognition, pages 2997–3004. IEEE, 2012.
[185] Liu Yang and Rong Jin. Distance metric learning: A comprehensive survey. Michigan
State Universiy, 2(2):4, 2006.
[186] Fei Wang, Jimeng Sun, Tao Li, and Nikos Anerousis. Two heads better than one:
Metric+ active learning and its applications for it service classification. In 2009 Ninth
IEEE International Conference on Data Mining, pages 1022–1027. IEEE, 2009.
[187] Kilian Q Weinberger and Lawrence K Saul. Distance metric learning for large margin
nearest neighbor classification. Journal of Machine Learning Research, 10(Feb):207–244,
2009.
[188] Thomas Cover and Peter Hart. Nearest neighbor pattern classification. IEEE transac-
tions on information theory, 13(1):21–27, 1967.
[189] Sumit Chopra, Raia Hadsell, and Yann LeCun. Learning a similarity metric discrimina-
tively, with application to face verification. In 2005 IEEE Computer Society Conference
on Computer Vision and Pattern Recognition (CVPR’05), volume 1, pages 539–546.
IEEE, 2005.
[190] Kilian Q Weinberger and Lawrence K Saul. Fast solvers and efficient implementations
for distance metric learning. In Proceedings of the 25th international conference on
Machine learning, pages 1160–1167, 2008.
[191] Russell A Reeves, William W Schairer, and David S Jevsevar. The national burden of
periprosthetic hip fractures in the us: costs and risk factors for hospital readmission.
HIP International, 29(5):550–557, 2019.
79
[192] E Anne Nelson, Mark E Maruish, and Joel L Axler. Effects of discharge planning and
compliance with outpatient appointments on readmission rates. Psychiatric services,
51(7):885–889, 2000.
[193] Mary Charlson, Ted P Szatrowski, Janey Peterson, and Jeffrey Gold. Validation of a
combined comorbidity index. Journal of clinical epidemiology, 47(11):1245–1251, 1994.
[194] Hude Quan, Vijaya Sundararajan, Patricia Halfon, Andrew Fong, Bernard Burnand,
Jean-Christophe Luthi, L Duncan Saunders, Cynthia A Beck, Thomas E Feasby, and
William A Ghali. Coding algorithms for defining comorbidities in icd-9-cm and icd-10
administrative data. Medical care, pages 1130–1139, 2005.
[195] Harlan M Krumholz, Ya-Ting Chen, Yun Wang, Viola Vaccarino, Martha J Radford,
and Ralph I Horwitz. Predictors of readmission among elderly survivors of admission
with heart failure. American heart journal, 139(1):72–77, 2000.
[196] Douglas G Altman, Yvonne Vergouwe, Patrick Royston, and Karel GM Moons. Prog-
nosis and prognostic research: validating a prognostic model. Bmj, 338:b605, 2009.
[197] Shivapratap Gopakumar, Truyen Tran, Tu Dinh Nguyen, Dinh Phung, and Svetha
Venkatesh. Stabilizing high-dimensional prediction models using feature graphs. IEEE
journal of biomedical and health informatics, 19(3):1044–1052, 2014.
[198] Matthias Schmid, Hans A Kestler, and Sergej Potapov. On the validity of time-
dependent auc estimators. Briefings in Bioinformatics, 16(1):153–168, 2015.
[199] Hajime Uno, Tianxi Cai, Michael J Pencina, Ralph B D’Agostino, and LJ Wei. On the
c-statistics for evaluating overall adequacy of risk prediction procedures with censored
survival data. Statistics in medicine, 30(10):1105–1117, 2011.
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APPENDICES
Below list the selected features after each step under the GBM scenario and all the
names are given by the authors rather than the original names appear in the EHRs system.
1. 30-day Hip fracture readmission
• Simple average of ranking
– After the embedded step (42)
Lab3 [27.0, 76.0), Los [7days, 14days), preInp1Y [2, ), Lab5 [1.2, 5.9), Los [14days,
600days), Gender, Discharge to SNF/SB/LTH, P5D84, Age[65, 75), P5D64,
cci 3, Lab3 [5.0, 11.0), Lab4 [9.0, 9.7), preInp1Y 1, P5D8, P157, P5D95,
cci 2, Lab4 [11.1, 15.1), Age [90, 100), Lab1 [140.0, 147.0), Lab3 [15.0, 19.0),
P12, P5D70, Lab5 [0.6, 0.76), P5D66, P5D114, P5D238, Lab2 [268.0, 513.0),
preER1Y 2,, P5D53, Lab3 [19.0, 27.0), P5D56, Lab0 [4.4, 5.6), Lab6 [26.9,
28.8), preInp3M 1, Discharge to Rehab or STH, epn 3, preInp6M 1, P72,
P5D259, P5D78
– After the wrapper step (21)
Lab3 [27.0, 76.0), Los [7days, 14days), preInp1Y [2, ), Los [14days, 600days),
Discharge to SNF/SB/LTH, P5D64, cci 3, Lab3 [5.0, 11.0), preInp1Y 1, P157,
P5D95, Age [90, 100), P12, P5D66, P5D114, P5D238, Lab2 [268.0, 513.0),
Lab3 [19.0, 27.0), Discharge to Rehab/STH, preInp6M 1, P72
• Weighted average of ranking
– After the embedded step (15)
Lab3 [27.0, 76.0), Los [7days, 14days), preInp1Y [2, ), Lab5 [1.2, 5.9), Los [14days,
600days), Gender, Discharge to SNF/SB/LTH, P5D84, Age [65, 75), P5D64,
cci 3, Lab3 [5.0, 11.0), Lab4 [9.0, 9.7), preInp1Y 1, P5D8
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– After the wrapper step (14)
Lab3 [27.0, 76.0), Los [7days, 14days), preInp1Y 2, Lab5 [1.2, 5.9), Los [14days,
600days), Gender, Discharge to SNF/SB/LTH, P5D84, Age [65, 75), P5D64,
cci 3, Lab3 [5.0, 11.0), Lab4 [9.0, 9.7), preInp1Y 1
2. Diabetic retinopathy prognosis
• Simple average of ranking
– After the embedded step (17)
creatinine, HbA1c, WBC, age, BUN, platelet, glucose, albumin, ALP, AST,
BPD, BPS, potassium, protein, Hematocrit, race AfricanAmerican, ALT
– After the wrapper step (15)
creatinine, HbA1c, WBC, age, BUN, glucose, albumin, platelet, ALP, AST,
BPD, BPS, potassium, protein, Hematocrit
• Weighted average of ranking
– After the embedded step (17)
creatinine, HbA1c, WBC, age, BUN, glucose, albumin, platelet, AST, ALP,
potassium, BPS, BPD, Hematocrit, protein, calcium, ALT
– After the wrapper step (13)
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